High-grade Salivary Gland Mucoepidermoid Carcinoma
2 clinical trials · Condition
◉ Watch High-grade Salivary Gland Mucoepidermoid Carcinoma
| Record | Firm | Date |
|---|---|---|
| Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer (NCT00126607) | National Cancer Institute (NCI) | 2005-07-01 |
| Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers (NCT00095563) | National Cancer Institute (NCI) | 2004-09-01 |
Track High-grade Salivary Gland Mucoepidermoid Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.